Log In
BCIQ
Print this Print this
 

Autologous dendritic cells

  Manage Alerts
Collapse Summary General Information
Company Amphera B.V.
DescriptionAutologous dendritic cells pulsed with allogeneic tumour cell lysate
Molecular Target
Mechanism of Action 
Therapeutic ModalityActive immunotherapy
Latest Stage of DevelopmentPhase I
Standard IndicationMesothelioma
Indication DetailsTreat malignant mesothelioma
Regulatory Designation U.S. - Orphan Drug (Treat malignant mesothelioma);
EU - Orphan Drug (Treat malignant mesothelioma)
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today